Bear Mountain Capital’s AbbVie ABBV Stock Holding History

Bear Mountain Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28K	Hold	114	–	–	0.01%	76
2026 Q1	$23.1K	Buy	114 +1	+0.9%	+$222	0.01%	82
2025 Q4	$24.5K	Sell	113 -97	-46%	-$22.1K	0.01%	83
2025 Q3	$48.6K	Buy	210 +1	+0.5%	+$204	0.02%	69
2025 Q2	$39.6K	Buy	209 +173	+481%	+$32.2K	0.01%	70
2025 Q1	$7K	Buy	36 +22	+157%	+$4.28K	﹤0.01%	109
2024 Q4	$2.35K	Hold	14	–	–	﹤0.01%	120
2024 Q3	$2.62K	Hold	14	–	–	﹤0.01%	120
2024 Q2	$2.3K	Buy	14 +1	+8%	+$166	﹤0.01%	130
2024 Q1	$2.2K	Hold	13	–	–	﹤0.01%	164
2023 Q4	$2.14K	Buy	+13	New	+$1.9K	﹤0.01%	168

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Bear Mountain Capital's ABBV Position: Q2 2026 in Review

Bear Mountain Capital held its AbbVie (ABBV) position steady in Q2 2026 at 114 shares worth $28K. The position accounts for 0.01% of the portfolio, ranked #76.

Bear Mountain Capital first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $48.6K in Q3 2025. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Bear Mountain Capital held 114 shares of AbbVie worth $28K as of Q2 2026.
Bear Mountain Capital left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.01% of Bear Mountain Capital's portfolio in Q2 2026, its #76 holding.
Bear Mountain Capital first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
Bear Mountain Capital's AbbVie position peaked at $48.6K in Q3 2025.
1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bear Mountain Capital's 13F filing for Q2 2026, filed 20 Jul 2026.